Back

Prevention of early sudden cardiac death after myocardial infarction using the wearable cardioverter defibrillator - results from a real-life cohort

3 April 2022 (11:00 - 11:48)
Organised by:
Congress Presentation Part of: Moderated ePosters - Variety of news on device therapy Device Treatment EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Ursula Rohrer

Medical University of Graz, Graz (Austria)

6 More presentations in this session

Presentation thumbnail
Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure
Doctor A. Mazza (Orvieto, IT)
Presentation thumbnail
Implantable cardioverter-defibrillator therapy in the very young - Patient characteristics procedural outcome and one-year follow-up - A subgroup analysis of the german DEVICE registry
Doctor D. Chung (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Age-related differences and associated outcomes of S-ICD: insights from a large, european, multicenter, real-world registry
Doctor M. Schiavone (Milan, IT)
Abstract Slides
Presentation thumbnail
Real-world survival of model-3501 subcutaneous implantable defibrillator lead
Doctor F. Migliore (Padova, IT)
Presentation thumbnail
Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry
Doctor L. Kaiser (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters - Variety of news on device therapy

The Event

Event poster

EHRA 2022

3 April 2022 11:00 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Congress Session
Ventricular tachycardia ablation in challenging scenarios: case-based management strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources